<drug type="small molecule" created="2015-12-03" updated="2016-08-17">
  <drugbank-id primary="true">DB11280</drugbank-id>
  <name>Anhydrous dextrose</name>
  <description/>
  <cas-number/>
  <unii/>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>Haemonetics Additive Solution Formula 3 (as-3)</name>
      <labeller>Haemonetics Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>57826-460</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-01-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number>BN000127</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Haemonetics Additive Solution Formula 3 (as-3)</name>
      <labeller>Haemonetics Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>57826-462</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-01-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number>BN000127</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (cp2d)</name>
      <labeller>Haemonetics Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>57826-455</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-01-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number>BN000127</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (cp2d)</name>
      <ingredients>Citric Acid + Trisodium citrate dihydrate + Sodium phosphate, monobasic, monohydrate + Anhydrous dextrose</ingredients>
    </mixture>
    <mixture>
      <name>Haemonetics Additive Solution Formula 3 (as-3)</name>
      <ingredients>Citric Acid + Sodium phosphate, monobasic, monohydrate + Sodium Chloride + Adenine + Anhydrous dextrose + Trisodium citrate dihydrate</ingredients>
    </mixture>
    <mixture>
      <name>Haemonetics Additive Solution Formula 3 (as-3)</name>
      <ingredients>Citric Acid + Sodium phosphate, monobasic, monohydrate + Sodium Chloride + Adenine + Anhydrous dextrose + Trisodium citrate dihydrate</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Carbohydrates</category>
      <mesh-id>D002241</mesh-id>
    </category>
    <category>
      <category>Chemical Actions and Uses</category>
      <mesh-id>D020164</mesh-id>
    </category>
    <category>
      <category>Diet, Food, and Nutrition</category>
      <mesh-id>D000066888</mesh-id>
    </category>
    <category>
      <category>Flavoring Agents</category>
      <mesh-id>D005421</mesh-id>
    </category>
    <category>
      <category>Food</category>
      <mesh-id>D005502</mesh-id>
    </category>
    <category>
      <category>Food Additives</category>
      <mesh-id>D005503</mesh-id>
    </category>
    <category>
      <category>Food and Beverages</category>
      <mesh-id>D019602</mesh-id>
    </category>
    <category>
      <category>Hexoses</category>
      <mesh-id>D006601</mesh-id>
    </category>
    <category>
      <category>Monosaccharides</category>
      <mesh-id>D009005</mesh-id>
    </category>
    <category>
      <category>Physiological Phenomena</category>
      <mesh-id>D010829</mesh-id>
    </category>
    <category>
      <category>Specialty Uses of Chemicals</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Sweetening Agents</category>
      <mesh-id>D013549</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Solution</form>
      <route>Extracorporeal</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties/>
  <experimental-properties/>
  <external-identifiers/>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>
